# Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy

> **NCT04141475** · NA · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 13 (actual)

## Conditions studied

- Diabetic Cardiomyopathies

## Interventions

- **DIETARY_SUPPLEMENT:** Physiomance acide lipoïque gold
- **DIETARY_SUPPLEMENT:** Placebo - Physiomance acide lipoïque gold

## Key facts

- **NCT ID:** NCT04141475
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-24
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** no patient recruitment
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04141475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04141475, "Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04141475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*